Kwame Ulmer is a Venture Partner of Wavemaker Three-Sixty Health, an early-stage venture capital firm. Kwame leads the team in sourcing, diligence and support of medtech and diagnostic companies.

He created rubric for conducting expert diligence for investments in companies with over $300M in enterprise value. Kwame brings over two decades of experience evaluating medical technologies in the government and private sector and serving in senior operating roles at medical device companies to help companies successfully engage the FDA. He has personally evaluated more than 1,000 medical technologies in his career. He also served as Vice President,
Regulatory Affairs and Quality Assurance at Implant Direct, a Danaher Corporation operating company.

Kwame serves on the board of the Lincoln University Foundation, University of Virginia Licensing and Ventures Group, Essenvia, and California Life Sciences. He is also a lecturer and researcher in medtech innovation at the University of California, Los Angeles. Kwame founded MedTech Color, a nonprofit with a mission to advance the representation of persons of color in the medical device industry. He is also a lecturer at the University of Virginia. Kwame earned his B.S. in Physics from Lincoln University, and has two Masters degrees from the University of Virginia, in Materials Engineering and Business Administration.